Literature DB >> 1418024

Quantitative immunohistologic criteria are superior to the lymphocytic focus score criterion for the diagnosis of Sjögren's syndrome.

C Bodeutsch1, P C de Wilde, L Kater, J C van Houwelingen, F H van den Hoogen, A A Kruize, R J Hené, L B van de Putte, G P Vooijs.   

Abstract

OBJECTIVE: The aim of the present study was to evaluate the diagnostic value of quantitative immunohistologic criteria for Sjögren's syndrome (SS) in labial salivary gland biopsies.
METHODS: Quantitative immunohistologic examination was performed on labial salivary gland biopsy samples from 80 healthy controls, 32 patients with primary SS, 14 patients with secondary SS, 5 with "probable" SS, 36 with keratoconjunctivitis sicca (KCS) with a lymphocytic focus score less than 1 on the lip biopsy, and 18 with rheumatoid arthritis (RA) without clinical evidence of SS.
RESULTS: This is the first study to show that immunohistologic criteria for SS, based on the percentages of IgA-containing and IgG-containing plasma cells, are able to 1) confirm the diagnosis of SS in labial salivary glands of KCS patients in the absence of grade IV lymphocytic adenitis; and 2) distinguish between a grade IV focal lymphocytic adenitis in the labial salivary glands of SS patients and of RA patients without SS.
CONCLUSION: Quantitative immunohistologic criteria were shown to be much more sensitive and disease specific than the widely accepted grade IV lymphocytic adenitis criterion, which corresponds to a lymphocytic focus score greater than 1, and these criteria should be included in the international diagnostic criteria for Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1418024     DOI: 10.1002/art.1780350913

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

1.  Current Aspects of Pathogenesis in Sjögren's Syndrome.

Authors:  Michael Voulgarelis; Athanasios G Tzioufas
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-12       Impact factor: 5.346

Review 2.  [Is bioptic assurance reasonable in patients with Sjögren's syndrome? From focus score to diagnosing vasculitides].

Authors:  V Krenn; M Jakobs; J Kriegsmann; M G Krukemeyer; A Rieger
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

3.  [Labial salivary gland biopsy in Sjögren's syndrome].

Authors:  A Dankof; L Morawietz; E Feist
Journal:  Pathologe       Date:  2006-11       Impact factor: 1.011

4.  The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.

Authors:  C Vitali; H M Moutsopoulos; S Bombardieri
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

5.  Sjögren's syndrome: History, clinical and pathological features.

Authors:  A L Parke; W W Buchanan
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

6.  Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sjögren's syndrome.

Authors:  Michiel M Zandbelt; Judith Vogelzangs; Leo BA Van De Putte; Walther J Van Venrooij; Frank HJ Van Den Hoogen
Journal:  Arthritis Res Ther       Date:  2003-10-31       Impact factor: 5.156

7.  Histopathology, salivary flow and ultrasonography of the parotid gland: three complementary measurements in primary Sjögren's syndrome.

Authors:  Esther Mossel; Martha S van Ginkel; Erlin A Haacke; Suzanne Arends; Silvia C Liefers; Konstantina Delli; Jolien F van Nimwegen; Alja J Stel; Fred K L Spijkervet; Arjan Vissink; Bert van der Vegt; Frans G M Kroese; Hendrika Bootsma
Journal:  Rheumatology (Oxford)       Date:  2022-05-30       Impact factor: 7.046

8.  The role of a labial salivary gland biopsy in the diagnostic procedure for Sjögren's syndrome; a study of 94 cases.

Authors:  Dewi van Stein-Callenfels; Jonathan Tan; Elisabeth Bloemena; Richard M van Vugt; Alexandre E Voskuyl; Nathalie T Y Santana; Isaäc van der Waal
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-07-01

9.  Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome.

Authors:  Benjamin A Fisher; Roland Jonsson; Troy Daniels; Michele Bombardieri; Rachel M Brown; Peter Morgan; Stefano Bombardieri; Wan-Fai Ng; Athanasios G Tzioufas; Claudio Vitali; Pepe Shirlaw; Erlin Haacke; Sebastian Costa; Hendrika Bootsma; Valerie Devauchelle-Pensec; Timothy R Radstake; Xavier Mariette; Andrea Richards; Rebecca Stack; Simon J Bowman; Francesca Barone
Journal:  Ann Rheum Dis       Date:  2016-12-13       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.